fbpx

Alcon Completes Acquisition of LumiThera, Expands into Dry AMD Treatment

Alcon logo

Alcon has announced the completion of its acquisition of LumiThera, Inc., a company recognized for its light-based innovations in ophthalmology. The deal brings the Valeda® photobiomodulation (PBM) device into Alcon’s portfolio—the first and only technology shown to provide patients with early and intermediate dry age-related macular degeneration (AMD) an average one-line improvement in visual acuity after two years of treatment.

Until now, treatment options for dry AMD have been limited, with therapies typically introduced only at advanced stages of the disease. With Valeda PBM, Alcon enters the clinic-based retina space, complementing its long-standing leadership in surgical retina.

“Since Alcon entered the retina space in 1997, we’ve focused our efforts mainly in surgical, delivering leading products and solutions for the operating room. As we welcome LumiThera and Valeda PBM to Alcon, we move into the retina clinic and the dry AMD space,” said Ian Bell, SVP, Chief Operating Officer of Alcon.

The Valeda PBM device uses non-phototoxic light therapy delivered through three wavelengths. Clinical trial data from the LIGHTSITE I, II and III studies have shown consistent gains in visual acuity, with 97% of patients reporting no discomfort during treatments.

Dr. Allen C. Ho, Director of Retina Research at Wills Eye Hospital and Chairman of the Alcon Research Institute Executive Committee, highlighted the significance of the technology: “Treating dry AMD earlier—before the development of advanced disease—has always made sense, but we did not have technology that could improve vision until the introduction of Valeda PBM.”

Valeda PBM is already available in the U.S., as well as in several European and Latin American countries. Alcon plans to generate revenue from the technology in 2025 in existing approved markets and expand into additional countries beginning in 2026, pending regulatory approvals.

For more details, visit myValeda.com.

Source: Alcon

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

VSP Vision to Acquire Marcolin from PAI Partners and Minority Shareholders

VSP Vision logo 2025

VSP Vision has entered into a definitive agreement to acquire Marcolin from PAI Partners and other minority shareholders, marking a major strategic move in the global eyewear sector.

The acquisition represents a significant investment by VSP Vision to expand its eyewear portfolio and strengthen its global reach. Marcolin, founded in 1961 in Northern Italy, is recognized worldwide for its expertise in eyewear design, manufacturing, and distribution. Today, the company distributes collections in more than 125 countries, with a portfolio that includes Tom Ford, Zegna, Christian Louboutin, ic! berlin, Max Mara, Guess, and many other luxury and lifestyle brands.

“The addition of Marcolin is another example of our commitment to purposeful growth that will provide greater value for VSP members, clients, doctors, and key customers,” said Michael Guyette, President and CEO of VSP Vision. “With a portfolio of some of the world’s most sought-after brands and advanced in-house manufacturing capabilities, Marcolin will strongly complement our existing offerings through Marchon Eyewear.”

Fabrizio Curci, CEO & General Manager of Marcolin, emphasized the alignment of vision between the two companies: “With a shared passion for bringing the highest quality eyewear to as many people as possible, joining VSP Vision is a perfect fit. We look forward to combining our expertise, focus on craftsmanship, commitment to product innovation and complementary portfolios and geographic presence.”

Under the ownership of PAI Partners, Marcolin expanded its international footprint, enhanced operational efficiency, and strengthened its brand portfolio through acquisitions, licensing agreements, and renewals. “We are delighted to have backed Marcolin’s transformation into a world leader in the wholesale eyewear business,” said Raffaele Vitale, Partner at PAI.

The transaction, advised by CapM Advisors (financial) and Latham & Watkins (legal) on behalf of the shareholders, with Kirkland & Ellis LLP and Chiomenti advising VSP Vision, is expected to close in the fourth quarter of 2025, subject to customary regulatory approvals.

Source: VSP Vision Newsroom

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Ray-Ban Launches Ray-Ban.EXE Campaign Inspired by Korean Pop Culture

Ray-Ban EXE SHOT36_STAMPA

Ray-Ban has introduced a new global campaign, Ray-Ban.EXE, blending the visual language of Korean webtoons with dystopian storytelling to connect with younger audiences worldwide.

Unveiled on September 4 at the brand’s first-ever pop-up in Seongsu-dong, Seoul, Korea, the campaign reflects Ray-Ban’s growing alignment with Korean pop culture as a key influence for Gen Z identity and creativity. The launch event brought together cultural leaders from Seoul’s thriving creative scene, underlining the city’s role as a hub for global youth trends.

At the center of the campaign is an animated short film that depicts a world controlled by humanoid machines where individuality is erased. The story follows EV11, a robot assigned to destroy non-conforming objects, who discovers a pair of Ray-Ban Clubmaster sunglasses. The discovery sparks a memory and sense of identity, transforming EV11 into a human named Kim. He joins a group of rebels working to awaken others, symbolizing Ray-Ban’s positioning of its eyewear as more than accessories—tools for self-expression and liberation.

With Ray-Ban.EXE, the brand reinforces its reputation for challenging convention and embracing cultural innovation. By drawing on Korean creative influence, Ray-Ban is positioning itself to resonate with a new generation of consumers around the globe.

Click HERE for the full press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

The Vision Council Releases New Research Spotlighting Optical Market Trends for Second Quarter of 2025

The Vision Council logo

The Vision Council released new market data and analysis reporting on the performance of the $17.4 billion optical industry for the second quarter of 2025. The Market inSights Q2 2025 report reveals industry performance across a variety of categories, including eye exams, eyeglasses, frames, lenses, contact lenses, readers and plano sunglasses. 

As is expected with seasonal shopping trends inherent in the optical sector, the second quarter of 2025 saw a $800 million decline in sales compared to the first quarter. The market value also experienced a year-over-year decline of 1.5 percent. All products, except for plano sunglasses, also experienced a decline in sales volume from the first quarter of the year.

“The second quarter data reflects both the challenges and resilience within the optical industry,” said Alysse Henkel, Vice President of Research and inSights. “While overall market value softened compared to the first quarter, we continue to see consistent demand for core vision care, including comprehensive eye exams and prescription lenses. At the same time, consumer preferences show a willingness to pay more per exam or frame — suggesting that consumers are still investing in their eyecare and eyewear even as sales volumes have decreased. These patterns provide valuable insight for businesses as they navigate a changing marketplace and plan for the remainder of 2025.” 

Key Highlights from Q2:

  • The market value of exams for Q2 2025 is 14 percent higher than Q2 2024, but the market volume decreased year-over-year by 4.5 percent. With these estimates, the average value of an exam in Q2 is almost $17 more than it was one year ago.
  • Lenses led the prescription market in value and were up nearly four percent from Q2 2024.
  • Compared to 2024, the volume of frames sold is down, while the average value of a pair of frames has increased by an estimated $21.
  • The average value of a pair of plano sunglasses purchased decreased both year-over-year and quarter-over-quarter.
  • The market volume of readers remained steady compared to Q1 2025, but overall, the market volume and value for readers has decreased since Q2 2024.
  • The contact lenses market had a seven percent decrease in volume compared to Q2 2024, but only a one percent decrease compared to Q1 2025.

The 2025 quarterly estimates are based on a variety of data sources, including consumer retail credit card spending data, patient billing and payment data, and optical retail location data, along with a robust consumer survey program. The data sources used in this report are routinely updated. Adjustments may be made to previously published estimates. 

The full report is available in The Vision Council’s Research Download Center. Members of The Vision Council can access immediately at no cost, while non-members can purchase the report directly for $1,000. 

For more information about the Market inSights report or The Vision Council’s research program, visit thevisioncouncil.org.  

Source: The Vision Council

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Seneca Polytechnic Partners with I-MED Pharma on Eyelid Hygiene Research

Seneca Polytechnic logo

Montreal-based I-MED Pharma and Seneca Polytechnic’s School of Biological Sciences and Applied Chemistry (BSAC) have collaborated on a study evaluating the performance of I-LID ‘N LASH HOCl Cleansing Spray, one of I-MED Pharma’s eyelid hygiene products designed for patients with dry eye.

The project brought together I-MED Pharma’s R&D team, led by Dr. Mahmoud B. Rammal, Dr. Adel Al-Amodi, and Dr. Karim Fahmy, with Seneca faculty Dr. Frank Merante and Paulina Sarzala, and research scientist Sina Elahipanah. Their work, published in the Biomedical Journal of Scientific and Technical Research, focused on methods to evaluate the concentration and stability of hypochlorous acid (HOCl) in the formulation. HOCl is an antimicrobial molecule naturally produced by the human body and serves as the active ingredient in the cleansing spray.

To avoid handling dangerous pathogens, the Seneca team tested the product against safer model organisms that mimic bacterial, fungal, and viral activity. “Some of these mimetic systems are incredibly valuable to mirror what would happen with pathogenic organisms,” said Dr. Merante.

Hands-on contributions came from Seneca students Dean Pickett, Amina Abane Cherrez, and Misako Kobayashi, all from the three-year Biotechnology – Advanced diploma program. The students carried out much of the lab work and analysis at the Seneca Centre for Innovation in Life Sciences (SCILS).

“It was such a great experience to interact with students who truly wanted to learn and excel,” said Sarzala. “They did an amazing job quantifying results in a reliable way.”

I-MED Pharma, which has specialized in dry eye solutions for more than 30 years, highlighted the value of Seneca’s facilities and expertise. “Seneca’s state-of-the-art facilities and advanced equipment played a pivotal role in streamlining the project and ensuring that key deliverables were achieved efficiently and on schedule,” said Dr. Al-Amodi.

Looking ahead, I-MED Pharma and Seneca expressed enthusiasm for continued collaboration. “Our priority has always been to validate the performance of our products through credible, data-driven research—and Seneca has proven to be a reliable partner in delivering exactly that,” said Dr. Rammal.

Source: Seneca Polytechnic

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Featured Posts

Vision Expo Orlando 2026

Vision Expo 2026 Marks 40th Anniversary with Strong Orlando Showing

Vision Expo 2026 celebrated its 40th anniversary in Orlando with more than 8,000 attendees, over 220 hours of education, and a show floor packed with innovation and industry activity.

Learn More
Starting a myopia management program

Getting Started in Myopia Management: Practical Steps to Build Confidence and Deliver Better Care

Myopia management has become an essential part of modern pediatric eye care. For many practices, the challenge is no longer why it matters, but how to integrate it into everyday clinical workflows.

Read more
Customeyes and Eyes on Sheppard logos 2026

CUSTOMEYES to Open First Global Atelier at Eyes On Sheppard in Toronto

CUSTOMEYES, the luxury eyewear customization platform by MIO Group, will open its first global Atelier at Eyes On Sheppard in Toronto on April 10, 2026.

Read more
EssilorLuxottica

EssilorLuxottica and Dolce&Gabbana Further Strengthen Their Partnership Through 2050

EssilorLuxottica and Dolce&Gabbana have announced a long-term extension of their licensing agreement through 2050 for prescription frames and sunglasses worldwide.

Read more
SightGlass DOT logos 2026

SightGlass Vision Strengthens Myopia Control Leadership with Two Appointments

SightGlass Vision has made two leadership appointments to strengthen its medical and professional affairs teams supporting DOT myopia control spectacle lenses.

Read more
Vision Expo Orlando 2026

Vision Expo 2026 Marks 40th Anniversary with Strong Orlando Showing

Vision Expo 2026 celebrated its 40th anniversary in Orlando with more than 8,000 attendees, over 220 hours of education, and a show floor packed with innovation and industry activity.

Learn More
Starting a myopia management program

Getting Started in Myopia Management: Practical Steps to Build Confidence and Deliver Better Care

Myopia management has become an essential part of modern pediatric eye care. For many practices, the challenge is no longer why it matters, but how to integrate it into everyday clinical workflows.

Read More
Customeyes and Eyes on Sheppard logos 2026

CUSTOMEYES to Open First Global Atelier at Eyes On Sheppard in Toronto

CUSTOMEYES, the luxury eyewear customization platform by MIO Group, will open its first global Atelier at Eyes On Sheppard in Toronto on April 10, 2026.

Read More
EssilorLuxottica

EssilorLuxottica and Dolce&Gabbana Further Strengthen Their Partnership Through 2050

EssilorLuxottica and Dolce&Gabbana have announced a long-term extension of their licensing agreement through 2050 for prescription frames and sunglasses worldwide.

Read More
SightGlass DOT logos 2026

SightGlass Vision Strengthens Myopia Control Leadership with Two Appointments

SightGlass Vision has made two leadership appointments to strengthen its medical and professional affairs teams supporting DOT myopia control spectacle lenses.

Read More
Vision Expo Orlando 2026

Vision Expo 2026 Marks 40th Anniversary with Strong Orlando Showing

Vision Expo 2026 celebrated its 40th anniversary in Orlando with more than 8,000 attendees, over 220 hours of education, and a show floor packed with innovation and industry activity.

Learn More
Starting a myopia management program

Getting Started in Myopia Management: Practical Steps to Build Confidence and Deliver Better Care

Myopia management has become an essential part of modern pediatric eye care. For many practices, the challenge is no longer why it matters, but how to integrate it into everyday clinical workflows.

Read more
Customeyes and Eyes on Sheppard logos 2026

CUSTOMEYES to Open First Global Atelier at Eyes On Sheppard in Toronto

CUSTOMEYES, the luxury eyewear customization platform by MIO Group, will open its first global Atelier at Eyes On Sheppard in Toronto on April 10, 2026.

Read more
EssilorLuxottica

EssilorLuxottica and Dolce&Gabbana Further Strengthen Their Partnership Through 2050

EssilorLuxottica and Dolce&Gabbana have announced a long-term extension of their licensing agreement through 2050 for prescription frames and sunglasses worldwide.

Read more
SightGlass DOT logos 2026

SightGlass Vision Strengthens Myopia Control Leadership with Two Appointments

SightGlass Vision has made two leadership appointments to strengthen its medical and professional affairs teams supporting DOT myopia control spectacle lenses.

Read more
Vision Expo Orlando 2026

Vision Expo 2026 Marks 40th Anniversary with Strong Orlando Showing

Vision Expo 2026 celebrated its 40th anniversary in Orlando with more than 8,000 attendees, over 220 hours of education, and a show floor packed with innovation and industry activity.

Learn More
Starting a myopia management program

Getting Started in Myopia Management: Practical Steps to Build Confidence and Deliver Better Care

Myopia management has become an essential part of modern pediatric eye care. For many practices, the challenge is no longer why it matters, but how to integrate it into everyday clinical workflows.

Read more
Customeyes and Eyes on Sheppard logos 2026

CUSTOMEYES to Open First Global Atelier at Eyes On Sheppard in Toronto

CUSTOMEYES, the luxury eyewear customization platform by MIO Group, will open its first global Atelier at Eyes On Sheppard in Toronto on April 10, 2026.

Read more
EssilorLuxottica

EssilorLuxottica and Dolce&Gabbana Further Strengthen Their Partnership Through 2050

EssilorLuxottica and Dolce&Gabbana have announced a long-term extension of their licensing agreement through 2050 for prescription frames and sunglasses worldwide.

Read more
SightGlass DOT logos 2026

SightGlass Vision Strengthens Myopia Control Leadership with Two Appointments

SightGlass Vision has made two leadership appointments to strengthen its medical and professional affairs teams supporting DOT myopia control spectacle lenses.

Read more